Corsair Gaming Inc vs Tempus AI — how do they compare? Corsair Gaming Inc trades at $13.22 (market cap $1.42B), while Tempus AI trades at $70.2 (market cap $12.58B). The key difference: Tempus AI is far larger — about 8.9× Corsair Gaming Inc's market cap, and Corsair Gaming Inc is trading nearer its 52-week high, Tempus AI nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Corsair Gaming Inc for 25 Days and Tempus AI for 22 Days on average.
| CRSR | TEM | |
|---|---|---|
Market Cap | $1.42B | $12.58B |
Volume | 1,160,938 | 7,444,569 |
Sector | Technology | Broad Market / Factor |
52-Week High | $14.35 | $99.28 |
52-Week Low | $4.58 | $41.55 |
Typical Hold Time | 25 Days | 22 Days |
Enterprise Value | $1.41B | $13.21B |
Signals from Pluang's Aura AI — not financial advice
Corsair Gaming (CRSR) trades at $13.59, down slightly by 0.37% on the day. The stock exhibits a bullish technical signal with recent earnings beats in Q4 2025, Q1 2026, and Q2 2026. Revenue for 2025 was $1.47 billion, though net income was negative $16.16 million. The company launched new products like the VOXARA microphone and acquired Trak Racer assets, signaling growth initiatives. Analyst consensus is a 'Hold' with a price target of $12.40, below the current price, indicating caution despite positive momentum.
The outlook for CRSR is mixed; strong earnings performance and product innovation offer upside, but valuation concerns and negative net income pose risks. Investors should weigh the bullish technical trends and recent institutional interest against the high P/E ratio of 42.23 and analyst price targets suggesting limited near-term gains. Key risks include competitive pressures and execution challenges in the gaming hardware market.
Tempus AI (TEM) trades at $70.29, down 2.35% on the day, with a bullish technical signal despite recent weakness. The company reported Q2 2026 revenue growth of 22% year-over-year and beat EPS estimates for three consecutive quarters, though it remains unprofitable with a net income margin of -17.77%. Recent positive developments include FDA clearance for its ECG-MR AI product and expanded data licensing agreements, fueling investor optimism in the healthtech sector.
The investment outlook is cautiously optimistic, driven by strong analyst support (64% buy ratings) and a consensus price target of $72.60, implying modest upside. Key opportunities include accelerating adoption of AI-powered diagnostics and strategic acquisitions, but risks persist from persistent cash burn, insider selling, and intense competition in the precision medicine space.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Corsair Gaming Inc is engaged in the business of providing high-performance gear for gamers and content creators. The product portfolio includes Cases, Keyboards, Mice, Headsets, Power Supplies, Gaming Computers, Gaming Chairs, Mousepads, and other related products. The company operates in two segments namely, Gamer and Creator peripherals, which is the key revenue generating segment
Read more on CRSR →Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →